Stonepine Capital Management, LLC Quant / Systematic

CIK: 0001440771 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value ($000): $241,108 (100.0% shares, 0.0% debt)

Holdings (28)

— AMRYT PHARMA PLC - SPNR ADR 21.7%

Value ($000) $52,417 Shares 6,338,200 Est. Cost $12.42 Unrealized —

— CTI BIOPHARMA CORP 9.1%

Value ($000) $21,876 Shares 4,684,404 Est. Cost $2.49 Unrealized —

XERS XERIS BIOPHARMA HOLDINGS INC 8.4%

Value ($000) $20,286 Shares 7,924,056 Est. Cost $2.24 Unrealized +9.0%

— AMARIN CORP PLC -ADR 6.7%

Value ($000) $16,163 Shares 4,912,714 Est. Cost $3.29 Unrealized —

OVID OVID THERAPEUTICS INC 5.5%

Value ($000) $13,245 Shares 4,218,069 Est. Cost $3.43 Unrealized -8.2%

ADMA ADMA BIOLOGICS INC 5.4%

Value ($000) $13,051 Shares 7,131,808 Est. Cost $1.31 Unrealized +18.7%

— ANTARES PHARMA INC 5.3%

Value ($000) $12,834 Shares 3,130,192 Est. Cost $3.72 Unrealized —

— CONFORMIS INC 4.5%

Value ($000) $10,780 Shares 17,281,386 Est. Cost $0.75 Unrealized —

— APOLLO ENDOSURGERY INC 4.3%

Value ($000) $10,248 Shares 1,693,834 Est. Cost $5.72 Unrealized —

XGN EXAGEN INC 3.7%

Value ($000) $9,002 Shares 1,121,040 Est. Cost $12.22 Unrealized -29.5%

ENTA ENANTA PHARMACEUTICALS INC 3.5%

Value ($000) $8,540 Shares 119,972 Est. Cost $65.07 Unrealized 0.0%

LGND LIGAND PHARMACEUTICALS 3.4%

Value ($000) $8,291 Shares 73,700 Est. Cost $72.55 Unrealized 0.0%

— OPTINOSE INC 3.0%

Value ($000) $7,228 Shares 2,926,416 Est. Cost $1.62 Unrealized —

— QUIDEL CORP 2.9%

Value ($000) $6,949 Shares 61,791 Est. Cost $112.46 Unrealized —

EOLS EVOLUS INC 2.7%

Value ($000) $6,577 Shares 586,224 Est. Cost $7.42 Unrealized +14.9%

ATYR ATYR PHARMA INC 1.3%

Value ($000) $3,218 Shares 601,580 Est. Cost $6.39 Unrealized -11.4%

DMAC DIAMEDICA THERAPEUTICS INC 1.2%

Value ($000) $2,993 Shares 1,197,245 Est. Cost $4.07 Unrealized -30.3%

— SYNLOGIC INC 1.1%

Value ($000) $2,554 Shares 1,064,135 Est. Cost $3.01 Unrealized —

RZLT REZOLUTE INC 1.0%

Value ($000) $2,531 Shares 748,702 Est. Cost $5.84 Unrealized -34.1%

URGN UROGEN PHARMA LTD 1.0%

Value ($000) $2,342 Shares 268,833 Est. Cost $7.80 Unrealized 0.0%

— SURGALIGN HOLDINGS INC 0.9%

Value ($000) $2,244 Shares 7,375,678 Est. Cost $0.30 Unrealized —

CELC CELCUITY INC 0.9%

Value ($000) $2,239 Shares 239,433 Est. Cost $20.31 Unrealized -48.8%

— CIDARA THERAPEUTICS INC 0.9%

Value ($000) $2,079 Shares 2,496,520 Est. Cost $1.47 Unrealized —

XOMA XOMA CORP 0.4%

Value ($000) $1,030 Shares 36,803 Est. Cost $20.24 Unrealized +12.7%

— AERIE PHARMACEUTICALS INC 0.4%

Value ($000) $854 Shares 93,900 Est. Cost $9.09 Unrealized —

ANIP ANI PHARMACEUTICALS INC 0.3%

Value ($000) $733 Shares 26,060 Est. Cost $42.97 Unrealized -13.2%

— MARINUS PHARMACEUTICALS INC 0.2%

Value ($000) $531 Shares 56,747 Est. Cost $9.36 Unrealized —

NMTC NEUROONE MEDICAL TECHNOLOGIE 0.1%

Value ($000) $273 Shares 248,105 Est. Cost $2.70 Unrealized -25.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	AMRYT PHARMA PLC - SPNR ADR	6,338,200	$52,417	21.7%	$12.42	—	SPONSORED ADS	03217L106
—	CTI BIOPHARMA CORP	4,684,404	$21,876	9.1%	$2.49	—	COM	12648L601
XERS	XERIS BIOPHARMA HOLDINGS INC	7,924,056	$20,286	8.4%	$2.24	+9.0%	COM	98422E103
—	AMARIN CORP PLC -ADR	4,912,714	$16,163	6.7%	$3.29	—	SPONS ADR NEW	023111206
OVID	OVID THERAPEUTICS INC	4,218,069	$13,245	5.5%	$3.43	-8.2%	COM	690469101
ADMA	ADMA BIOLOGICS INC	7,131,808	$13,051	5.4%	$1.31	+18.7%	COM	000899104
—	ANTARES PHARMA INC	3,130,192	$12,834	5.3%	$3.72	—	COM	036642106
—	CONFORMIS INC	17,281,386	$10,780	4.5%	$0.75	—	COM	20717E101
—	APOLLO ENDOSURGERY INC	1,693,834	$10,248	4.3%	$5.72	—	COM	03767D108
XGN	EXAGEN INC	1,121,040	$9,002	3.7%	$12.22	-29.5%	COM	30068X103
ENTA	ENANTA PHARMACEUTICALS INC	119,972	$8,540	3.5%	$65.07	0.0%	COM	29251M106
LGND	LIGAND PHARMACEUTICALS	73,700	$8,291	3.4%	$72.55	0.0%	COM NEW	53220K504
—	OPTINOSE INC	2,926,416	$7,228	3.0%	$1.62	—	COM	68404V100
—	QUIDEL CORP	61,791	$6,949	2.9%	$112.46	—	COM	74838J101
EOLS	EVOLUS INC	586,224	$6,577	2.7%	$7.42	+14.9%	COM	30052C107
ATYR	ATYR PHARMA INC	601,580	$3,218	1.3%	$6.39	-11.4%	COM NEW	002120202
DMAC	DIAMEDICA THERAPEUTICS INC	1,197,245	$2,993	1.2%	$4.07	-30.3%	COM NEW	25253X207
—	SYNLOGIC INC	1,064,135	$2,554	1.1%	$3.01	—	COM	87166L100
RZLT	REZOLUTE INC	748,702	$2,531	1.0%	$5.84	-34.1%	COM NEW	76200L309
URGN	UROGEN PHARMA LTD	268,833	$2,342	1.0%	$7.80	0.0%	COM	M96088105
—	SURGALIGN HOLDINGS INC	7,375,678	$2,244	0.9%	$0.30	—	COM	86882C105
CELC	CELCUITY INC	239,433	$2,239	0.9%	$20.31	-48.8%	COM	15102K100
—	CIDARA THERAPEUTICS INC	2,496,520	$2,079	0.9%	$1.47	—	COM	171757107
XOMA	XOMA CORP	36,803	$1,030	0.4%	$20.24	+12.7%	COM NEW	98419J206
—	AERIE PHARMACEUTICALS INC	93,900	$854	0.4%	$9.09	—	COM	00771V108
ANIP	ANI PHARMACEUTICALS INC	26,060	$733	0.3%	$42.97	-13.2%	COM	00182C103
—	MARINUS PHARMACEUTICALS INC	56,747	$531	0.2%	$9.36	—	COM NEW	56854Q200
NMTC	NEUROONE MEDICAL TECHNOLOGIE	248,105	$273	0.1%	$2.70	-25.1%	COM NEW	64130M209